New structures of the glucagon-like peptide-1 (GLP-1) and glucagon receptors in complex with peptide and nonpeptide ligands provide a comprehensive, detailed picture of the molecular mechanisms of action of family B GPCRs. This opens the door for true structure-based drug discovery aimed at both novel orthosteric and allosteric subsites of the receptors.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
137,91 €
only 11,49 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Zhang, Y. et al. Nature 546, 248–253 (2017).
Jazayeri, A. et al. Nature 546, 254–258 (2017).
Song, G. et al. Nature 546, 312–315 (2017).
Zhang, H. et al. Nature 546, 259–264 (2017).
Hjorth, S.A. & Schwartz, T.W. Acta Physiol. Scand. 157, 343–345 (1996).
Liang, Y.L. et al. Nature 546, 118–123 (2017).
Rasmussen, S.G. et al. Nature 477, 549–555 (2011).
Sparre-Ulrich, A.H. et al. Biochem. Pharmacol. 131, 78–88 (2017).
Jazayeri, A. et al. Nature 533, 274–277 (2016).
Nolte, W.M. et al. Nat. Chem. Biol. 10, 629–631 (2014).
Author information
Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Schwartz, T., Frimurer, T. Full monty of family B GPCRs. Nat Chem Biol 13, 819–821 (2017). https://doi.org/10.1038/nchembio.2438
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.2438